FDA Approved: ENDARI — Original Application (Emmaus Medical, Inc.)

View source ↗

Summary

FDA approved ENDARI (L-glutamine) from Emmaus Medical, Inc. for reducing acute complications in patients with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• ENDARI (GLUTAMINE)

Snippet

ORIG AP for ENDARI (GLUTAMINE)